Healthcare is one of the largest and most defensively positioned sectors in global equity markets, encompassing hospitals, medical devices, diagnostics, and managed care. Intuitive Surgical dominates robotic surgery, Thermo Fisher Scientific supplies research and diagnostic tools, and UnitedHealth Group leads in managed care and pharmacy benefit services. Danaher and Abbott operate diversified life science platforms spanning instruments, diagnostics, and medical devices.
1
4.7
Intuitive Surgical
ISRG
$485.84
+1.51%
P/E: 71.5
Intuitive Surgical is a healthcare stock at the intersection of medical technology and innovation, with its da Vinci robotic surgical systems installed in hospitals worldwide performing millions of minimally invasive procedures annually, generating high-margin recurring revenue from instruments, acc
2
4.6
Thermo Fisher Scientific
TMO
$504.82
-0.98%
P/E: 46.4
Thermo Fisher Scientific is the world's largest life sciences tools and diagnostics company, providing essential instruments, reagents, and services to hospitals, laboratories, pharmaceutical companies, and research institutions globally.
3
4.6
Vertex Pharmaceuticals
VRTX
$491.47
+5.69%
P/E: 35.0
Vertex is a leading healthcare innovator expanding beyond cystic fibrosis into pain, gene editing, and kidney disease, with a pipeline of potentially transformative therapies that could address large unmet medical needs.
4
4.4
Danaher
DHR
$212.58
-1.10%
P/E: 36.8
Danaher provides critical instruments, diagnostics, and services to healthcare customers worldwide through its life sciences and diagnostics segments, which together generate the majority of the company's revenue and profits.
5
4.1
Abbott Laboratories
ABT
$112.68
+1.09%
P/E: 20.8
Abbott Laboratories is a diversified healthcare stock with leading positions in medical devices, diagnostics, nutrition, and pharmaceuticals, offering investors balanced exposure to multiple healthcare growth drivers anchored by its fast-growing FreeStyle Libre glucose monitoring franchise and a dec
6
4.1
Medtronic
MDT
$99.49
-1.38%
P/E: 30.2
Medtronic is the world's largest pure-play medical device company, with leadership positions in cardiac rhythm management, surgical robotics, spinal therapies, and diabetes care that make it a foundational healthcare sector holding.
7
4.0
Becton Dickinson
BDX
$175.89
-1.08%
P/E: 12.7
Becton Dickinson supplies the syringes, needles, IV catheters, diagnostic systems, and medication management platforms that hospitals and clinics around the world depend on daily, making it an indispensable healthcare stock.
8
4.0
CRISPR Therapeutics
CRSP
$53.07
+8.46%
P/E: 2.9
CRISPR Therapeutics is developing potentially curative therapies for genetic blood disorders, cancer, diabetes, and other serious diseases, representing transformative healthcare innovation that could change how medicine treats the root causes of illness.
9
4.0
UnitedHealth Group
UNH
$293.19
+3.10%
P/E: 13.2
UnitedHealth Group is the largest healthcare stock by both revenue and market capitalization, combining the nation's biggest health insurance operation with the rapidly growing Optum health services platform to create a vertically integrated healthcare enterprise that touches nearly every aspect of
Latest from Otrai
Every trader has a strategy that looks great in their head. Backtesting is how you find out whether it actually works. Here is how to test strategies properly, what metrics matter, and why most backtest results are too good to be true.
A risk-reward ratio compares how much you stand to lose on a trade to how much you stand to gain. It is arguably the most important number in your trading plan, because it determines whether your strategy can survive a normal losing streak.
Every month, a handful of economic data releases move the forex market more in five minutes than most sessions move in five days. Non-Farm Payrolls, CPI prints, and central bank rate decisions create violent spikes, whipsaws, and trend shifts that can make or break a trading account.
A CFD is a contract between you and your broker to exchange the difference in an asset's price from when you open the trade to when you close it. You never own the underlying asset. That single distinction shapes everything about how CFDs work, what they cost, and why regulators treat them differently from traditional investing.